SECALIP Side Effects

6775144-X | Rhabdomyolysis
on Jun 08, 2010 Female patient from GERMANY , 74 years of age, was diagnosed with hypercholesterolaemia and was treated with Secalip (View Usage). Patient experienced the following unwanted or unexpected effects: rhabdomyolysis. Secalip dosage: . During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ).

6635371-9 | Pulmonary Fibrosis
Patient was taking Secalip (View Usage). Patient had the following side effects: pulmonary fibrosis (What is pulmonary fibrosis?) on Mar 05, 2010 from GERMANY Additional patient health information: Male patient , 68 years of age, was diagnosed with hypercholesterolaemia and. Secalip dosage: .

6631706-1 | Pulmonary Fibrosis
Adverse event was reported on Mar 03, 2010 by a Male patient taking Secalip (View Usage) (Dosage: ) was diagnosed with hypercholesterolaemia and. Location: GERMANY , 68 years of age, After Secalip was administered, patient had the following side effects: pulmonary fibrosis (What is pulmonary fibrosis?).

6619041-9 | Pulmonary Fibrosis
on Feb 26, 2010 Male patient from GERMANY , 68 years of age, was diagnosed with hypercholesterolaemia and was treated with Secalip (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary fibrosis (What is pulmonary fibrosis?). Secalip dosage: .


6607458-8 | Pulmonary Fibrosis
on Feb 19, 2010 Male patient from GERMANY , 68 years of age, was diagnosed with hypercholesterolaemia and was treated with Secalip (View Usage). Patient had the following side effects: pulmonary fibrosis (What is pulmonary fibrosis?). Secalip dosage: .

6578577-X | Tendon Rupture
Patient was taking Secalip (View Usage). After Secalip was administered, patient had the following side effects: tendon rupture on Feb 02, 2010 from GERMANY Additional patient health information: Male patient , 29 years of age, was diagnosed with hypertriglyceridaemia and. Secalip dosage: 160mg Daily. Patient was hospitalized.

6293735-X | Coagulopathy
Adverse event was reported on Jul 24, 2009 by a Male patient taking Secalip (View Usage) (Dosage: ) . Location: GERMANY , 63 years of age, Patient experienced the following unwanted or unexpected effects: coagulopathy. During the same period patient was treated with ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), QUINAPRIL HYDROCHLORIDE (View Quinapril Hydrochloride Review and Quinapril Hydrochloride Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), CLORAZEPATE DIPOTASSIUM (View Clorazepate Dipotassium Review and Clorazepate Dipotassium Label ).

5619137-4 | Congenital Cystic Kidney Disease, Hepatic Lesion, Renal Failure Chronic, Rhabdomyolysis
on Jan 30, 2008 Male patient from GERMANY , 40 years of age, was diagnosed with hypercholesterolaemia, immunisation and was treated with Secalip (View Usage). Patient had the following side effects: congenital cystic kidney disease, hepatic lesion, renal failure chronic, rhabdomyolysis. Secalip dosage: . During the same period patient was treated with HEPATITIS B SURFACE ANTIGEN (20 Mcg/1ml) (View Hepatitis B Surface Antigen Review and Hepatitis B Surface Antigen Label ), INFLUENZA VIRUS VACCINE POLYVALENT (View Influenza Virus Vaccine Polyvalent Review and Influenza Virus Vaccine Polyvalent Label ). Patient was hospitalized.

5595013-0 | Cholestasis, Jaundice
on Jan 08, 2008 Male patient from GERMANY , 45 years of age, was treated with Secalip (View Usage). After Secalip was administered, patient had the following side effects: cholestasis, jaundice (What is jaundice?). Secalip dosage: . During the same period patient was treated with RANITIDINE (View Ranitidine Review and Ranitidine Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ), ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ). Patient was hospitalized.

5385855-9 | Blood Urea Increased, Rhabdomyolysis
Patient was taking Secalip (View Usage). Patient experienced the following unwanted or unexpected effects: blood urea increased, rhabdomyolysis on Jul 02, 2007 from GERMANY Additional patient health information: Female patient , 55 years of age, . Secalip dosage: . During the same period patient was treated with VENLAFAXIINE HCL (View Venlafaxiine Hcl Review and Venlafaxiine Hcl Label ), CLORAZEPATE DIPOTASSIUM (View Clorazepate Dipotassium Review and Clorazepate Dipotassium Label ), TOLTERODINE TARTRATE (View Tolterodine Tartrate Review and Tolterodine Tartrate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), FENTANYL TRANSDERMAL SYSTEM (View Fentanyl Transdermal System Review and Fentanyl Transdermal System Label ). Patient was hospitalized.

5053219-3 | Rash Pustular
Adverse event was reported on Jul 07, 2006 by a Male patient taking Secalip (View Usage) (Dosage: ) . Location: FRANCE , 73 years of age, Patient had the following side effects: rash pustular. During the same period patient was treated with ZUCLOPENTHIXOL DECANOATE (View Zuclopenthixol Decanoate Review and Zuclopenthixol Decanoate Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

5016118-9 | Anorexia, Chromaturia, Faeces Discoloured, Hepatitis Cholestatic, Influenza Like Illness, Jaundice, Pain
on May 22, 2006 Female patient from FRANCE , 60 years of age, was diagnosed with hypercholesterolaemia and was treated with Secalip (View Usage). After Secalip was administered, patient had the following side effects: anorexia, chromaturia, faeces discoloured, hepatitis cholestatic, influenza like illness, jaundice (What is jaundice?), pain (What is pain?). Secalip dosage: . During the same period patient was treated with FLAVOXATE HCL (View Flavoxate Hcl Review and Flavoxate Hcl Label ). Patient was hospitalized.

4933733-9 | Dyspepsia, Oedema Mouth, Pharyngeal Oedema, Stomatitis, Throat Irritation
on Feb 27, 2006 Female patient from FRANCE , weighting 141.1 lb, was diagnosed with hypercholesterolaemia, venous insufficiency and was treated with Secalip (View Usage). Patient experienced the following unwanted or unexpected effects: dyspepsia, oedema mouth, pharyngeal oedema, stomatitis, throat irritation. Secalip dosage: . During the same period patient was treated with ESBERIVEN FORTE (View Esberiven Forte Review and Esberiven Forte Label ).

4598918-2 | Asthenia, Diarrhoea, Headache, Liver Disorder, Myalgia, Pyrexia, Renal Disorder, Shock, Toxic Epidermal Necrolysis
Patient was taking Secalip (View Usage). Patient had the following side effects: asthenia, diarrhoea, headache (What is headache?), liver disorder, myalgia, pyrexia, renal disorder, shock, toxic epidermal necrolysis on Jan 26, 2005 from Additional patient health information: Male patient , weighting 185.2 lb, was diagnosed with hypercholesterolaemia, limb discomfort and. Secalip dosage: . During the same period patient was treated with CELECOXIB (View Celecoxib Review and Celecoxib Label ), CHRYSANTELLUM AMERICANUM (View Chrysantellum Americanum Review and Chrysantellum Americanum Label ). Patient was hospitalized.

4587982-2 | Asthenia, Diarrhoea, Liver Disorder, Myalgia, Pyrexia, Renal Disorder, Toxic Epidermal Necrolysis
Adverse event was reported on Jan 26, 2005 by a Male patient taking Secalip (View Usage) (Dosage: ) was diagnosed with hypercholesterolaemia, limb discomfort, sleep disorder (What is sleep disorder?) and. Location: , weighting 185.2 lb, After Secalip was administered, patient had the following side effects: asthenia, diarrhoea, liver disorder, myalgia, pyrexia, renal disorder, toxic epidermal necrolysis. During the same period patient was treated with CELECOXIB (View Celecoxib Review and Celecoxib Label ), HERBAL PREPARATION (View Herbal Preparation Review and Herbal Preparation Label ). Patient was hospitalized.

4575783-0 | Cyst, Pancreatic Cyst, Pancreatitis Haemorrhagic, Pancreatitis Necrotising
on Jan 31, 2005 Female patient from , weighting 97.00 lb, was diagnosed with hypercholesterolaemia, rhinitis allergic and was treated with Secalip (View Usage). Patient experienced the following unwanted or unexpected effects: cyst, pancreatic cyst, pancreatitis haemorrhagic, pancreatitis necrotising. Secalip dosage: . During the same period patient was treated with LIPANTHYL TABLETS (View Lipanthyl Tablets Review and Lipanthyl Tablets Label ), LEVOCETIRIZINE DIHYDROCHLORIDE (View Levocetirizine Dihydrochloride Review and Levocetirizine Dihydrochloride Label ). Patient was hospitalized.

4571392-8 | Liver Disorder, Myalgia, Pyrexia, Renal Disorder, Toxic Epidermal Necrolysis
on Jan 26, 2005 Male patient from , 54 years of age, was diagnosed with hypercholesterolaemia, limb discomfort, sleep disorder (What is sleep disorder?) and was treated with Secalip (View Usage). Patient had the following side effects: liver disorder, myalgia, pyrexia, renal disorder, toxic epidermal necrolysis. Secalip dosage: . During the same period patient was treated with CELECOXIB (View Celecoxib Review and Celecoxib Label ), HERBAL PREPARATION (View Herbal Preparation Review and Herbal Preparation Label ). Patient was hospitalized.